These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 3901881)

  • 1. Quantitative determination of dibekacin using radioimmunoassay, substrate-labelled fluorescent immunoassay and rate nephelometric inhibition immunoassay for tobramycin.
    Duriez D; Dewilde A; Marzin D; Wattré P
    Ann Inst Pasteur Microbiol (1985); 1985; 136A(3):381-8. PubMed ID: 3901881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Substrate-labeled fluorescent immunoassay for measuring dibekacin concentrations in serum and plasma.
    Place JD; Thompson SG
    Antimicrob Agents Chemother; 1983 Aug; 24(2):240-5. PubMed ID: 6357071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Immunologic analysis of dibekacin in human serum: comparison of 4 methods].
    Lesne M; Mebsout F; Jacqmin P
    J Pharm Belg; 1983; 38(2):69-75. PubMed ID: 6875794
    [No Abstract]   [Full Text] [Related]  

  • 4. Rapid method for determination of kanamycin and dibekacin in serum by use of high-pressure liquid chromatography.
    Kubo H; Kobayashi Y; Nishikawa T
    Antimicrob Agents Chemother; 1985 Oct; 28(4):521-3. PubMed ID: 4073874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The distribution of aminoglycoside antibiotics into the lymph and pancreatic fluid in dogs (author's transl)].
    Lee YG
    Jpn J Antibiot; 1980 May; 33(5):558-73. PubMed ID: 7431657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pharmacokinetic studies on intravenous drip infusion of dibekacin in elderly subjects without apparent renal failure (author's transl)].
    Sawae Y; Okada K; Umemura K
    Jpn J Antibiot; 1982 Mar; 35(3):770-8. PubMed ID: 7097979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of a method for enzymic radiochemical assay of tobramycin and amikacin in serum.
    McKnight RP; Willis JE
    Clin Chem; 1981 Jul; 27(7):1256-61. PubMed ID: 7237793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of enzyme immunoassay, radioimmunoassay, and microbiologic assay for amikacin in plasma.
    Fukuchi H; Yoshida M; Tsukiai S; Kitaura T; Konishi T
    Am J Hosp Pharm; 1984 Apr; 41(4):690-3. PubMed ID: 6372450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunoassay Analysis of Kanamycin in Serum Using the Tobramycin Kit.
    Dijkstra JA; Voerman AJ; Greijdanus B; Touw DJ; Alffenaar JW
    Antimicrob Agents Chemother; 2016 Aug; 60(8):4646-51. PubMed ID: 27185806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparative in vitro activity of dibekacin, gentamicin and tobramycin on 617 bacterial strains].
    Coulet M; Brun Y; Forey F; Fleurette J
    Nouv Presse Med; 1982 Nov; 11(46):3391-5. PubMed ID: 7155846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dibekacin assay in serum by automated fluorescence polarization immunoassay (Abbott Tdx): comparison with high-performance liquid chromatography, substrate-labelled fluorescent immunoassay and radioimmunoassay.
    Rollman B; Van der Auwera P; Tulkens PM
    J Pharm Biomed Anal; 1986; 4(1):53-61. PubMed ID: 16867630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An evaluation of the homogeneous substrate-labeled fluorescent immunoassay for tobramycin in serum.
    Belpaire FM; Hallynck T; Pyck J
    Methods Find Exp Clin Pharmacol; 1982; 4(4):249-53. PubMed ID: 6750285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative evaluation of three methods for measuring gentamicin and tobramycin in serum.
    Ngui-Yen JH; Hofmann T; Wigmore M; Smith JA
    Antimicrob Agents Chemother; 1981 Dec; 20(6):821-5. PubMed ID: 7034643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Homogeneous enzyme immunoassay for tobramycin evaluated and compared with a radioimmunoassay.
    Woo J; Longley MA; Cannon DC
    Clin Chem; 1982 Jun; 28(6):1370-4. PubMed ID: 7042123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Neuromuscular blocking properties of tobramycin, dibekacin and ribostamycin in man (author's transl)].
    Arai T; Hashimoto Y; Shima T; Matsukawa S; Iwatsuki KI
    Jpn J Antibiot; 1977 Apr; 30(4):281-4. PubMed ID: 864858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determination of kanamycin concentration in serum by substrate-labeled fluorescent immunoassay.
    DeCastro AF; Place JD; Lam CT; Patel C
    Antimicrob Agents Chemother; 1986 Jun; 29(6):961-4. PubMed ID: 3524437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of four assay methods for determination of tobramycin in human serum.
    Acton WJ; Van Duyn OM; Allen LV; Flournoy DJ
    Clin Chem; 1982 Jan; 28(1):177-80. PubMed ID: 7035000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An enzyme immunoassay for serum tobramycin.
    Kominami G; Nakamura M; Mori S; Kono M
    Clin Chim Acta; 1981 Dec; 117(2):189-97. PubMed ID: 7030524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dibekacin intrarenal distribution characteristics and renal cortical elution kinetics. Comparison with gentamicin and tobramycin.
    Whelton A; Carter GG; Stout RL; Herbst DV; Bryant HH; Walker G
    J Clin Pharmacol; 1980; 20(8-9):518-25. PubMed ID: 7430416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Bone levels of dibekacin].
    Dellamonica P; Etesse H; Garraffo R; Giaume F; Bernard E; Argenson C
    Pathol Biol (Paris); 1984 May; 32(5):343-6. PubMed ID: 6739143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.